Ken Griffin Avita Medical, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.72 - $10.87 $71,796 - $101,091	9,300 Added 80.17%	20,900 $224,000
Q2 2024 Aug 14, 2024	SELL	$7.92 - $15.55 $64,944 - $127,510	-8,200 Reduced 41.41%	11,600 $91,000
Q1 2024 May 15, 2024	BUY	$12.56 - $18.31 $6,280 - $9,155	500 Added 2.59%	19,800 $317,000
Q4 2023 Feb 14, 2024	SELL	$9.29 - $14.57 $62,242 - $97,619	-6,700 Reduced 25.77%	19,300 $264,000
Q3 2023 Nov 14, 2023	SELL	$13.84 - $20.79 $279,568 - $419,958	-20,200 Reduced 43.72%	26,000 $379,000
Q2 2023 Aug 14, 2023	BUY	$10.7 - $17.48 $349,890 - $571,596	32,700 Added 242.22%	46,200 $785,000
Q1 2023 May 15, 2023	SELL	$6.45 - $14.48 $250,260 - $561,824	-38,800 Reduced 74.19%	13,500 $188,000
Q4 2022 Feb 14, 2023	SELL	$4.53 - $7.55 $159,909 - $266,515	-35,300 Reduced 40.3%	52,300 $345,000
Q3 2022 Nov 14, 2022	BUY	$4.97 - $7.89 $294,224 - $467,088	59,200 Added 208.45%	87,600 $462,000

5.96M

35.5K

38K

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $299M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.